Site US2688 — Detroit, Michigan

Site US2688 is a clinical research site located in Detroit, Michigan, United States 48201.

Crixeo Health Trust Score: 58/100 (POOR). This profile has not yet been claimed by the site owner.

Site US2688 has participated in 1 clinical trials.

Therapeutic areas: Advanced Malignancies, Positive for Anaplastic Lymphoma Kinase, Positive for Proto-Oncogene Tyrosine-Protein Kinase ROS.

Sponsors: Astellas Pharma Inc.

Sponsor Feasibility Report

Trust Score: 58/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Site US2688?

Site US2688 has a Crixeo Trust Score of 58/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Site US2688 conducted?

Site US2688 has 1 clinical trials on record. Their work covers Advanced Malignancies, Positive for Anaplastic Lymphoma Kinase, Positive for Proto-Oncogene Tyrosine-Protein Kinase ROS.

Is Site US2688 accredited by Crixeo Health?

Site US2688 has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Site US2688?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.